Taipei, May 7 (CNA) A rapid antibody test kit for COVID-19 developed by a local biomedical company that can deliver results in just 10 minutes has passed clinical trials and is ready for mass production, a company official said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Fourth round of rapid test rationing plan to start Aug. 15The fourth round of the government's COVID-19 rapid test kits rationing scheme will begin on Aug. 15, with every holder of a National Health Insurance (NHI) card or Alien ...08/12/2022 07:24 PM
- Taiwan reports 21,989 new COVID-19 cases, 31 deathsTaiwan on Friday reported 21,989 new cases of COVID-19 and 31 deaths from the disease, according to the Central Epidemic Command Center (CECC).08/12/2022 03:16 PM
- Taiwan reports 22,909 new COVID-19 cases, 44 deathsTaiwan on Thursday reported 22,909 new cases of COVID-19, all but 259 of which were domestic infections, as well as 44 deaths from the disease, according to the Central Epidemic ...08/11/2022 03:15 PM
Latest
- Business
Household income inequality in 2021 highest in 10 years: DGBAS
08/12/2022 09:32 PM - Business
Disposable income hike expected to reduce income tax next year
08/12/2022 09:20 PM - Politics
DPP's Taoyuan mayoral candidate pulls out over thesis plagiarism (update)
08/12/2022 08:35 PM - Business
Taiwan cuts GDP growth forecast for 2022 to 3.76%
08/12/2022 07:45 PM - Society
Fourth round of rapid test rationing plan to start Aug. 15
08/12/2022 07:24 PM